Cited by 792Alzheimer's disease research and treatmentsMitochondrial Function and PathologyDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction

Open access

Devi, Latha, Prabhu, Badanavalu M., Galati, Domenico F., Avadhani, Narayan G., Anandatheerthavarada, Hindupur K.·2006·The Journal of Neuroscience

DOI 10.1523/jneurosci.1469-06.2006PMC PMC6675337

Open this paper in CoChat — free account Open PDF

Abstract

Mitochondrial dysfunction is one of the major intracellular lesions of Alzheimer's disease (AD). However, the causative factors involved in the mitochondrial dysfunction in human AD are not well understood. Here we report that nonglycosylated full-length and C-terminal truncated amyloid precursor protein (APP) accumulates exclusively in the protein import channels of mitochondria of human AD brains but not in age-matched controls. Furthermore, in AD brains, mitochondrially associated APP formed stable approximately 480 kDa complexes with the translocase of the outer mitochondrial membrane 40 (TOM40) import channel and a super complex of approximately 620 kDa with both mitochondrial TOM40 and the translocase of the inner mitochondrial membrane 23 (TIM23) import channel TIM23 in an "N(in mitochondria)-C(out cytoplasm)" orientation. Accumulation of APP across mitochondrial import channels, which varied with the severity of AD, inhibited the entry of nuclear-encoded cytochrome c oxidase subunits IV and Vb proteins, which was associated with decreased cytochrome c oxidase activity and increased levels of H2O2. Regional distribution of mitochondrial APP showed higher levels in AD-vulnerable brain regions, such as the frontal cortex, hippocampus, and amygdala. Mitochondrial accumulation of APP was also observed in the cholinergic, dopaminergic, GABAergic, and glutamatergic neuronal types in the category III AD brains. The levels of translocationally arrested mitochondrial APP directly correlated with mitochondrial dysfunction. Moreover, apolipoprotein genotype analysis revealed that AD subjects with the E3/E4 alleles had the highest content of mitochondrial APP. Collectively, these results suggest that abnormal accumulation of APP across mitochondrial import channels, causing mitochondrial dysfunction, is a hallmark of human AD pathology.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1523/jneurosci.1469-06.2006

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form
Schägger, H., & von JAGOW, G. (1991) · Analytical Biochemistry · doi:10.1016/0003-2697(91)90094-a · Cited by 2,267
The cholinergic hypothesis of Alzheimer’s disease: A review of progress
Francis, P. T., Palmer, A. M., Snape, M., & Wilcock, G. K. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.2.137 · Cited by 2,198 · cited 1×
“In addition to cholinergic neurons, several other neuronal types, such as dopaminergic, GABAergic, and glutamatergic neurons, have been shown to be affected in the later stages of the pathogenesis of AD (Francis et al., 1999; Francis, 2003).”
Background
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease
HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447
Mitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367
Translating cell biology into therapeutic advances in Alzheimer's disease
Selkoe, D. J. (1999) · Nature · doi:10.1038/399a023 · Cited by 1,166
Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression
Manczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., & Reddy, P. H. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl066 · Cited by 1,104
Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease
(1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00057-2 · Cited by 981

Flagged first, then by citations

Show all 62 references

Research works printed but not linked: 2

Dasso M (1998) in Current protocols in cell biology, In vitro reconstitution, eds Bonifacino JS Dasso M Harford JB Lippincot-Schawartz J Yamada KM (Wiley, New York), pp 11.0.1–11.0.2.
Jagannatha Rao, 1999, Trace elements in the cerebrospinal fluid of Alzheimer’s disease, Alzheimers Rep, 2, 333

Sorted by citations

Items 301–400 of 790

Mitochondrial Disturbances, Tryptophan Metabolites and Neurodegeneration: Medicinal Chemistry Aspects
Szalárdy, L., Klivènyi, P., Zádori, D., Fülöp, F., Toldi, J., & Vécsei, L. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800167365 · Cited by 60
Biochemical deficits and cognitive decline in brain aging: Intervention by dietary supplements
Poddar, J., Pradhan, M., Ganguly, G., & Chakrabarti, S. (2018) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2018.04.002 · Cited by 63
Molecular Dysfunctions of Mitochondria-Associated Membranes (MAMs) in Alzheimer’s Disease
Eysert, F., Kinoshita, P. F., Mary, A., Vaillant-Beuchot, L., Checler, F., & Chami, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249521 · Cited by 63
New applications of disease genetics and pharmacogenetics to drug development
Roses, A. D., Saunders, A. M., Lutz, M. W., Zhang, N., Hariri, A. R., Asin, K. E., Crenshaw, D. G., Budur, K. S., Burns, D. K., & Brannan, S. K. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.12.002 · Cited by 59
Antioxidant Thymoquinone and Its Potential in the Treatment of Neurological Diseases
Исаев, Н. К., Генрихс, Е. Е., & Stelmashook, E. V. (2023) · Antioxidants · doi:10.3390/antiox12020433 · Cited by 62
Incorporation of β-sitosterol into mitochondrial membrane enhances mitochondrial function by promoting inner mitochondrial membrane fluidity
Shi, C., Wu, F., & Xu, J. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9495-3 · Cited by 60
Mitochondrial degeneration in dystrophic neurites of senile plaques may lead to extracellular deposition of fine filaments
Fiala, J. C., Feinberg, M. D., Peters, A., & Barbas, H. (2007) · Brain Structure and Function · doi:10.1007/s00429-007-0153-1 · Cited by 64
The Effects of APOE4 on Mitochondrial Dynamics and Proteins in vivo
Simonovitch, S., Schmukler, E., Masliah, E., Pinkas-Kramarski, R., & Michaelson, D. M. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-190074 · Cited by 59
Molecular docking of fisetin with AD associated AChE, ABAD and BACE1 proteins
Dash, R., Emran, T. B., Uddin, M. M. N., Islam, A., & Junaid, M. (2014) · Bioinformation · doi:10.6026/97320630010562 · Cited by 59
Mutations that affect mitochondrial functions and their association with neurodegenerative diseases
Dhillon, V. S., & Fenech, M. F. (2013) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2013.09.001 · Cited by 61
Mitochondrial Dysfunction and Stress Responses in Alzheimer’s Disease
Weidling, I. W., & Swerdlow, R. H. (2019) · Biology · doi:10.3390/biology8020039 · Cited by 59
Defective mitophagy and the etiopathogenesis of Alzheimer’s disease
Zeng, K., Yu, X., Mahaman, Y. A. R., Wang, J., Liu, R., Li, Y., & Wang, X. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00305-1 · Cited by 62
Mitochondrial preconditioning: a potential neuroprotective strategy
Correia, S. C. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00138 · Cited by 58
Mitochondria, Cognitive Impairment, and Alzheimer's Disease
Mancuso, M., Calsolaro, V., Orsucci, D., Carlesi, C., Choub, A., Piazza, S., & Siciliano, G. (2009) · International Journal of Alzheimer s Disease · doi:10.4061/2009/951548 · Cited by 58
Mitochondria and Alzheimer’s Disease: the Role of Mitochondrial Genetic Variation
Ridge, P. G., & Kauwe, J. S. K. (2018) · Current Genetic Medicine Reports · doi:10.1007/s40142-018-0132-2 · Cited by 58
Extracellular Vesicles and Damage-Associated Molecular Patterns: A Pandora’s Box in Health and Disease
Picca, A., Guerra, F., Calvani, R., Coelho‐Júnior, H. J., Landi, F., Bernabei, R., Romanò, R., Bucci, C., & Marzetti, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.601740 · Cited by 58
Mitochondrial Mutations
Lax, N., Turnbull, D. M., & Reeve, A. K. (2011) · The Neuroscientist · doi:10.1177/1073858411385469 · Cited by 80
The PINK1 kinase-driven ubiquitin ligase Parkin promotes mitochondrial protein import through the presequence pathway in living cells
Jacoupy, M., Hamon-Keromen, E., Ordureau, A., Erpapazoglou, Z., Cogé, F., Corvol, J., Nosjean, O., la Cour, C. M., Millan, M. J., Boutin, J. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47352-9 · Cited by 60
Impaired transport of mitochondrial transcription factor A (TFAM) and the metabolic memory phenomenon associated with the progression of diabetic retinopathy
dos Santos, J. M., & Kowluru, R. A. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2384 · Cited by 54
Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease
Manczak, M., Mao, P., Nakamura, K., Bebbington, C., Park, B., & Reddy, P. H. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp331 · Cited by 56
Disturbed sleep and diabetes: A potential nexus of dementia risk
Holingue, C., Wennberg, A. M. V., Berger, S., Polotsky, V. Y., & Spira, A. P. (2018) · Metabolism · doi:10.1016/j.metabol.2018.01.021 · Cited by 58
Mitochondrial Cascade Hypothesis of Alzheimer's Disease: Myth or Reality?
Mancuso, M., Coppedè, F., Murri, L., & Siciliano, G. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1761 · Cited by 56
Metabolic disorder in Alzheimer’s disease
Poddar, M. K., Banerjee, S., Chakraborty, A., & Dutta, D. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00673-z · Cited by 58
In search of biomarkers for leprosy by unraveling the host immune response to Mycobacterium leprae
van Hooij, A., & Geluk, A. (2021) · Immunological Reviews · doi:10.1111/imr.12966 · Cited by 55
Mitochondrial protein quality control in health and disease
Baker, M. J., Palmer, C. S., & Stojanovski, D. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12430 · Cited by 60
Large-scale De Novo Prediction of Physical Protein-Protein Association
Elefsinioti, A. L., Saraç, Ö. S., Hegele, A., Plake, C., Hubner, N. C., Poser, I., Sarov, M., Hyman, A. A., Mann, M., Schroeder, M., et al. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.010629 · Cited by 54
Mitochondrial dynamics changes with age in an APPsw/PS1dE9 mouse model of Alzheimer’s disease
Xu, L., Shen, Y., Wang, X., Wei, L., Wang, P., Yang, H., Wang, C.-F., Xie, Z., & Bi, J. (2017) · Neuroreport · doi:10.1097/wnr.0000000000000739 · Cited by 55
Decreased Accumulation of Subcellular Amyloid-β with Improved Mitochondrial Function Mediates the Neuroprotective Effect of Huperzine A
Yang, L., Ye, C.-Y., Huang, X., Tang, X.-C., & Zhang, H. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120274 · Cited by 55
Mitochondria and Alzheimer’s disease: amyloid-β peptide uptake and degradation by the presequence protease, hPreP
Alikhani, N., Ankarcrona, M., & Glaser, E. G. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9244-4 · Cited by 55
Mitochondria, cholesterol and amyloid β peptide: a dangerous trio in Alzheimer disease
Colell, A., Fernández, A., & Fernández-Checa, J. C. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9242-6 · Cited by 53
The biological foundation of the genetic association of TOMM40 with late-onset Alzheimer's disease
Zeitlow, K., Charlambous, L., Ng, I., Gagrani, S., Mihovilovic, M., Luo, S., Rock, D. L., Saunders, A. M., Roses, A. D., & Gottschalk, W. K. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.031 · Cited by 56
Structural and Functional Alterations in Mitochondria-Associated Membranes (MAMs) and in Mitochondria Activate Stress Response Mechanisms in an In Vitro Model of Alzheimer’s Disease
Fernandes, T., Resende, R., Silva, D. F., Marques, A. P., Santos, A. E., Cardoso, S. M., Domingues, M. R., Moreira, P. I., & Pereira, C. (2021) · Biomedicines · doi:10.3390/biomedicines9080881 · Cited by 56
Mitochondrial links between brain aging and Alzheimer’s disease
Wilkins, H., & Swerdlow, R. H. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00261-2 · Cited by 53
Protein carbonylation after traumatic brain injury: cell specificity, regional susceptibility, and gender differences
Lazarus, R. C., Buonora, J. E., Jacobowitz, D. M., & Mueller, G. P. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.10.507 · Cited by 53
Aging-Dependent Mitophagy Dysfunction in Alzheimer’s Disease
Song, M., Zhao, X., & Song, F. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02248-y · Cited by 59
Can Healthy Diets, Regular Exercise, and Better Lifestyle Delay the Progression of Dementia in Elderly Individuals?
George, E., & Reddy, P. H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190232 · Cited by 55
Mitochondrial Genomic Analysis of Late Onset Alzheimer’s Disease Reveals Protective Haplogroups H6A1A/H6A1B: The Cache County Study on Memory in Aging
Ridge, P. G., Maxwell, T. J., Corcoran, C. D., Norton, M. C., Tschanz, J. T., O’Brien, E., Kerber, R. A., Cawthon, R., Munger, R. G., & Kauwe, J. S. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045134 · Cited by 52
No consistent evidence for association between mtDNA variants and Alzheimer disease
Hudson, G., Sims, R., Harold, D. H., Chapman, J., Hollingworth, P., Gerrish, A., Russo, G., Hamshere, M. L., Moskvina, V., Jones, N., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31824e8f1d · Cited by 52
mPOS is a novel mitochondrial trigger of cell death – implications for neurodegeneration
Coyne, L. P., & Chen, X. J. (2017) · FEBS Letters · doi:10.1002/1873-3468.12894 · Cited by 51
From proliferative to neurological role of an hsp70 stress chaperone, mortalin
Deocaris, C. C., Kaul, S. C., & Wadhwa, R. (2008) · Biogerontology · doi:10.1007/s10522-008-9174-2 · Cited by 51
TOMM40 rs10524523 polymorphism's role in late-onset Alzheimer's disease and in longevity
Maruszak, A., Pepłońska, B., Safranow, K., Chodakowska-Żebrowska, M., Barcikowska, M., & Żekanowski, C. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110743 · Cited by 50
Oxidative stress accelerates amyloid deposition and memory impairment in a double-transgenic mouse model of Alzheimer's disease
Kanamaru, T., Kamimura, N., Yokota, T., Iuchi, K., Nishimaki, K., Takami, S., Akashiba, H., Shitaka, Y., Katsura, K., Kimura, K., et al. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.12.033 · Cited by 52
Environmental factors in the development and progression of late-onset Alzheimer’s disease
Wainaina, M. N., Chen, Z., & Zhong, C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1425-9 · Cited by 53
Therapeutic Potential of Multifunctional Tacrine Analogues
Przybyłowska, M., Kowalski, S., Dzierzbicka, K., & Inkielewicz‐Stępniak, I. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180412091908 · Cited by 51
The effects of bioactive components from the rhizome of Salvia miltiorrhiza (Danshen) on the characteristics of Alzheimer’s disease
Chong, C., Su, H., Lu, J., & Wang, Y. (2019) · Chinese Medicine · doi:10.1186/s13020-019-0242-0 · Cited by 52
Molecular Machinery and Pathophysiology of Mitochondrial Dynamics
Chiu, Y., Lin, S., Kuo, C.-H., & Li, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.743892 · Cited by 50
Towards Alzheimer's root cause: ECSIT as an integrating hub between oxidative stress, inflammation and mitochondrial dysfunction
Soler‐López, M., Badiola, N., Zanzoni, A., & Aloy, P. (2012) · BioEssays · doi:10.1002/bies.201100193 · Cited by 48
Upregulation of PGC ‐1α expression by A lzheimer's disease‐associated pathway: presenilin 1/amyloid precursor protein ( APP )/intracellular domain of APP
Robinson, A., Grösgen, S., Mett, J., Zimmer, V. C., Haupenthal, V. J., Hundsdörfer, B., Stahlmann, C. P., Slobodskoy, Y., Müller, U., Hartmann, T., et al. (2013) · Aging Cell · doi:10.1111/acel.12183 · Cited by 49
Molecular and biochemical trajectories from diabetes to Alzheimer’s disease: A critical appraisal
Sandhir, R., & Gupta, S. N. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i12.1223 · Cited by 49
Near infrared light decreases synaptic vulnerability to amyloid beta oligomers
Comerota, M. M., Krishnan, B., & Taglialatela, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-15357-x · Cited by 49
Activity of Selected Group of Monoterpenes in Alzheimer’s Disease Symptoms in Experimental Model Studies—A Non-Systematic Review
Wojtunik‐Kulesza, K. A., Rudkowska, M., Kasprzak‐Drozd, K., Oniszczuk, A., & Borowicz, K. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147366 · Cited by 51
The neurobiology and therapeutic potential of multi-targeting β-secretase, glycogen synthase kinase 3β and acetylcholinesterase in Alzheimer’s disease
Fronza, M. G., Alves, D. A. C., Praticò, D., & Savegnago, L. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102033 · Cited by 47
Mitochondrial protein import stress
Pfanner, N., den Brave, F., & Becker, T. (2025) · Nature Cell Biology · doi:10.1038/s41556-024-01590-w · Cited by 53
Amyloid β precursor protein as a molecular target for amyloid β–induced neuronal degeneration in Alzheimer's disease
Bignante, E. A., Heredia, F., Morfini, G. A., & Lorenzo, A. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.021 · Cited by 50
Membrane Biophysics and Mechanics in Alzheimer's Disease
Yang, X., Askarova, S., & Lee, J. C. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8121-9 · Cited by 49
Mitochondrial Perturbation in Alzheimer's Disease and Diabetes
Akhter, F., Chen, D., Yan, S. F., & Yan, S. S. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.019 · Cited by 48
Infusion of Plasma from Exercised Mice Ameliorates Cognitive Dysfunction by Increasing Hippocampal Neuroplasticity and Mitochondrial Functions in 3xTg-AD Mice
Kim, T.-W., Park, S.-S., Park, J., & Park, H.-S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093291 · Cited by 48
Mitochondrial DNA damage in a mouse model of Alzheimer's disease decreases amyloid beta plaque formation
Pinto, M., Pickrell, A. M., Fukui, H., & Moraes, C. T. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.014 · Cited by 47
TOMM40 Genetic Variants Cause Neuroinflammation in Alzheimer’s Disease
Chen, Y., Chang, S., Lee, Y., Ho, W.-M., Huang, Y.-H., Wu, Y.-Y., Chu, Y.-C., Wu, K.-H., Wei, L.-S., Wang, H., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044085 · Cited by 48
Early Molecular Changes in Alzheimer Disease: Can We Catch the Disease in its Presymptomatic Phase?
Wirz, K. T. S., Keitel, S., Swaab, D. F., Verhaagen, J., & Bossers, K. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130920 · Cited by 47
Key Role of Mitochondria in Alzheimer’s Disease Synaptic Dysfunction
Cavallucci, V., Ferraina, C., & D’Amelio, M. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319360005 · Cited by 47
Dual role of brain-derived extracellular vesicles in dementia-related neurodegenerative disorders: cargo of disease spreading signals and diagnostic-therapeutic molecules
Natale, F., Fusco, S., & Grassi, C. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00326-w · Cited by 49
The role of cytochrome c oxidase deficiency in ROS and amyloid plaque formation
Pickrell, A. M., Fukui, H., & Moraes, C. T. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9245-3 · Cited by 47
Simultaneous evaluation of substrate-dependent oxygen consumption rates and mitochondrial membrane potential by TMRM and safranin in cortical mitochondria
Chowdhury, S. R., Djordjevic, J., Albensi, B. C., & Fernyhough, P. (2015) · Bioscience Reports · doi:10.1042/bsr20150244 · Cited by 46
Mitochondrial Ca2+ handling in Huntington's and Alzheimer's diseases – Role of ER-mitochondria crosstalk
Naia, L., Ferreira, I. L., Ferreiro, E. B., & Rego, A. C. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.07.122 · Cited by 49
Brain pyrimidine nucleotide synthesis and Alzheimer disease
Pesini, A., Iglesias, E., Bayona‐Bafaluy, M. P., Garrido-Pérez, N., Meade, P., Gaudó, P., Jiménez-Salvador, I., Andrés‐Benito, P., Montoya, J., Ferrer, I., et al. (2019) · Aging · doi:10.18632/aging.102328 · Cited by 47
Contribution of Mitochondrial Dysfunction Combined with NLRP3 Inflammasome Activation in Selected Neurodegenerative Diseases
Litwiniuk, A., Baranowska-Bik, A., Domańska, A., Kalisz, M., & Bik, W. (2021) · Pharmaceuticals · doi:10.3390/ph14121221 · Cited by 46
Mechanisms of Mitochondrial Malfunction in Alzheimer’s Disease: New Therapeutic Hope
Nabi, S. U., Khan, A., Siddiqui, E. M., Rehman, M. U., Alshahrani, S., Arafah, A. M., Mehan, S., Alsaffar, R. M., Alexiou, A. T., & Shen, B. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4759963 · Cited by 51
The influence of APOE and TOMM40 polymorphisms on hippocampal volume and episodic memory in old age
Ferencz, B., Laukka, E. J., Lövdén, M., Kalpouzos, G., Keller, L., Graff, C., Wahlund, L., Fratiglioni, L., & Bäckman, L. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00198 · Cited by 45
Melatonin regulates the autophagic flux via activation of alpha‐7 nicotinic acetylcholine receptors
Jeong, J., & Park, S. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12235 · Cited by 45
Amyloid precursor protein drives down-regulation of mitochondrial oxidative phosphorylation independent of amyloid beta
Lopez Sanchez, M. I. G., Waugh, H. S., Tsatsanis, A., Wong, B. X., Crowston, J. G., Duce, J. A., & Trounce, I. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-10233-0 · Cited by 45
Inhibition of DNM1L and mitochondrial fission attenuates inflammatory response in fibroblast‐like synoviocytes of rheumatoid arthritis
Wang, X., Chen, Z., Fan, X., Li, W., Qu, J., Dong, C., Wang, Z., Zhen-wei, J., & Li, Y. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14837 · Cited by 47
Mitochondrial Quality Control Strategies: Potential Therapeutic Targets for Neurodegenerative Diseases?
Hu, D., Liu, Z., & Qi, X. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.746873 · Cited by 44
Mitochondrial medicine and the neurodegenerative mitochondriopathies
Swerdlow, R. H. (2009) · Pharmaceuticals · doi:10.3390/ph2030150 · Cited by 43
Real-time mechanisms of exacerbated synaptic remodeling by microglia in acute models of systemic inflammation and tauopathy
Cangalaya, C., Wegmann, S., Sun, W., Diez, L., Gottfried, A., Richter, K., Stoyanov, S., Pakan, J. M. P., Fischer, K., & Dityatev, A. E. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.02.023 · Cited by 48
N1-methylation of adenosine (m1A) in ND5 mRNA leads to complex I dysfunction in Alzheimer’s disease
Jörg, M., Plehn, J. E., Kristen, M., Lander, M., Walz, L., Lietz, C., Wijns, J., Pichot, F., Rojas-Charry, L., Martin, K., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02421-y · Cited by 43
Transcranial Electromagnetic Treatment Against Alzheimer's Disease: Why it has the Potential to Trump Alzheimer's Disease Drug Development
Arendash, G. W. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120943 · Cited by 46
Mitochondrial Dysfunction and Mitophagy Closely Cooperate in Neurological Deficits Associated with Alzheimer’s Disease and Type 2 Diabetes
Paul, S. C., Saha, D., & Binukumar, B. K. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02365-2 · Cited by 43
Immunosenescence and Aging: Neuroinflammation Is a Prominent Feature of Alzheimer’s Disease and Is a Likely Contributor to Neurodegenerative Disease Pathogenesis
Bowirrat, A. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12111817 · Cited by 46
Structural Neuroimaging Genetics Interactions in Alzheimer’s Disease
Moon, S. W., Dinov, I. D., Kim, J., Zamanyan, A., Hobel, S., Thompson, P. M., Toga, A. W., & Initiative, A. F. T. A. D. N. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150335 · Cited by 43
Dysfunction of Mitochondria in Alzheimer’s Disease: ANT and VDAC Interact with Toxic Proteins and Aid to Determine the Fate of Brain Cells
Atlante, A., Valenti, D., Latina, V., & Amadoro, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147722 · Cited by 44
A New Function of Human HtrA2 as an Amyloid-β Oligomerization Inhibitor
Kooistra, J., Milojevic, J., Melacini, G., & Ortega, J. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1037 · Cited by 45
Synergistic Exacerbation of Mitochondrial and Synaptic Dysfunction and Resultant Learning and Memory Deficit in a Mouse Model of Diabetic Alzheimer's Disease
Wang, Y., Wu, L., Li, J., Du, F., Zhong, C., Chen, J. X., & Yan, S. S. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140972 · Cited by 43
DNA methylation in the APOE genomic region is associated with cognitive function in African Americans
Liu, J., Zhao, W., Ware, E. B., Turner, S. T., Mosley, T. H., & Smith, J. A. (2018) · BMC Medical Genomics · doi:10.1186/s12920-018-0363-9 · Cited by 45
Protective Effect of Bajijiasu Against β-Amyloid-Induced Neurotoxicity in PC12 Cells
Chen, D., Zhang, P., Lin, L., Shuai, O., He-Ming, Z., Liu, S., & Wang, J.-Y. (2013) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-013-9950-7 · Cited by 42
Regional brain metabolism with cytochrome c oxidase histochemistry in a PS1/A246E mouse model of autosomal dominant Alzheimer's disease: Correlations with behavior and oxidative stress
Strazielle, C., Jazi, R., Verdier, Y., Qian, S., & Lalonde, R. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.08.005 · Cited by 43
A Direct Interaction Between Mitochondrial Proteins and Amyloid-β Peptide and its Significance for the Progression and Treatment of Alzheimer’s Disease
Benek, O., Aitken, L., Hroch, L., Kuča, K., Gunn‐Moore, F. J., & Musílek, K. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150114163051 · Cited by 41
Mitochondrial Cholesterol in Alzheimer's Disease and Niemann–Pick Type C Disease
Torres, S., García‐Ruiz, C., & Fernández-Checa, J. C. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01168 · Cited by 42
TOMM40 RNA Transcription in Alzheimer’s Disease Brain and Its Implication in Mitochondrial Dysfunction
Lee, E.-G., Chen, S., Leong, L., Tulloch, J., & Yu, C. (2021) · Genes · doi:10.3390/genes12060871 · Cited by 41
N-Acetyl-Cysteine: Modulating the Cysteine Redox Proteome in Neurodegenerative Diseases
Martínez, M. (2022) · Antioxidants · doi:10.3390/antiox11020416 · Cited by 46
RNA silencing of genes involved in Alzheimer's disease enhances mitochondrial function and synaptic activity
Mańczak, M., & Reddy, P. H. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.008 · Cited by 41
Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer’s Disease
Afsar, A., Castro, M. D. C. C., Soladogun, A. S., & Li, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087258 · Cited by 45
ATAD1 prevents clogging of TOM and damage caused by un-imported mitochondrial proteins
Kim, J., Goldstein, M., Zecchel, L., Ghorayeb, R., Maxwell, C. A., & Weidberg, H. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114473 · Cited by 45
Substrate specificity of the TIM22 mitochondrial import pathway revealed with small molecule inhibitor of protein translocation
Hasson, S. A., Damoiseaux, R. D., Glavin, J. D., Dabir, D. V., Walker, S. S., & Koehler, C. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914387107 · Cited by 40
Mitochondria and Alzheimer's disease
Piaceri, I., Rinnoci, V., Bagnoli, S., Failli, Y., & Sorbi, S. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.05.033 · Cited by 40
An update on the toxicity of Aβ in Alzheimer’s disease
Götz, J. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3016 · Cited by 40
Non-tau based neuronal degeneration in Alzheimer's disease — an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex
van de Nes, J. A. P., Nafe, R., & Schlote, W. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.043 · Cited by 42
Amyloid precursor protein‐mediated mitochondrial regulation and Alzheimer's disease
Lopez Sanchez, M. I. G., van Wijngaarden, P., & Trounce, I. A. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14554 · Cited by 45
The effect of TOMM40 on spatial navigation in amnestic mild cognitive impairment
Laczó, J., Andel, R., Vyhnálek, M., Maťoška, V., Kaplan, V., Nedelská, Z., Lerch, O., Gažová, I., Moffat, S. D., & Hort, J. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.03.004 · Cited by 41
Axonal Transport and Mitochondrial Dysfunction in Alzheimer's Disease
Riemer, J., & Kins, S. (2012) · Neurodegenerative Diseases · doi:10.1159/000342020 · Cited by 39

Authors: Devi, L., Prabhu, B. M., Galati, D. F., Avadhani, N. G., & Anandatheerthavarada, H. K.
Affiliations: University of Pennsylvania (US)
ORCID: Galati, Domenico F.
Avadhani, Narayan G.
Venue: The Journal of Neuroscience
Publisher: Society for Neuroscience
Published: 2006-08-30
Volume: 26
Issue: 35
Pages: 9057-9068
ISSN: 0270-6474 (ISSN-L)
1529-2401
DOI: 10.1523/jneurosci.1469-06.2006
PMC: PMC6675337
OpenAlex: W2076241970
Cited by: 792
References: 62
Citations by year: 2026: 21 · 2025: 21 · 2024: 36 · 2023: 47 · 2022: 53 · 2021: 60 · 2020: 50 · 2019: 37 · 2018: 44 · 2017: 39 · 2016: 36 · 2015: 35 · 2014: 34 · 2013: 40 · 2012: 50
FWCI: 19.78
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-sa
creativecommons.org/licenses/by-nc-sa/4.0/ (vor, 182 d)
Locations: Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Institute on Aging (R01AG021920, AG 021920)
National Institute of General Medical Sciences (GM-49683, R01GM049683)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: amyloid precursor protein, Alzheimer's disease, mitochondrial dysfunction, Tom40, Tim23, cytochrome c oxidase, hydrogen peroxide, neuronal cell types
MeSH terms: Alzheimer Disease, Apolipoproteins E, Biological Transport, Brain, Cadaver, Electron Transport Complex IV, Glycosylation, Humans, Hydrogen Peroxide, Mitochondria, Neurons, Tissue Distribution, Case-Control Studies, Amyloid beta-Protein Precursor, Mitochondrial Proteins, Mitochondrial Membrane Transport Proteins, Mitochondrial Membranes, Apolipoprotein E3, Apolipoprotein E4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks